IL15 and melanoma: In vitro expanded tetramer+ CD8+ T cells were cultured with rapamycin (100nM) for 3 days immediately before transfer into IL-15-treated or non-treated melanoma-bearing recipients that were injected i.v. with Mel 624 melanoma cells (1×105 per mouse).